Galderma (formerly known as Nestle Skin Health), a portfolio company of EQT, has sold its baby skincare subsidiary Bübchen to Dallmann's Pharma, a wholly owned subsidiary of Germany-based confectionery group Katjes.
Additive manufacturing-focused firm has a target of €100m for the vehicle
With LDC's support, the company intends to boost its international growth and explore complementary acquisitions
Goldman Sachs and Kennet Partners are expected to make a 5x return on their investment in Nuxeo
Acquisition of the cybersecurity and identity firm is backed by BGF and Santander Growth Capital